The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Plasma Fractionation-Global Market Insights and Sales Trends 2025
Synopsis
Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Plasma Fractionation.
The global Plasma Fractionation market size is expected to reach US$ 47210 million by 2029, growing at a CAGR of 7.6% from 2023 to 2029. The market is mainly driven by the significant applications of Plasma Fractionation in various end use industries. The expanding demands from the Immunology, Hematology and Others,, are propelling Plasma Fractionation market. Albumin, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Immune Globulin segment is estimated at % CAGR for the next seven-year period.
Global Plasma Fractionation key players include Takeda, CSL, Grifols, Octapharma, Kedrion, etc. Global top five manufacturers hold a share about 75%.
North America is the largest market, with a share over 40%, followed by Europe and China, both have a share about 40 percent.
In terms of product, Immune Globulin is the largest segment, with a share about 50%. And in terms of application, the largest application is Immunology, followed by Hematology.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Plasma Fractionation, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Plasma Fractionation market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Plasma Fractionation market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Plasma Fractionation sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Plasma Fractionation covered in this report include Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL and RAAS, etc.
The global Plasma Fractionation market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Global Plasma Fractionation market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Plasma Fractionation market, Segment by Type:
Albumin
Immune Globulin
Coagulation Factor
Others
Global Plasma Fractionation market, by Application
Immunology
Hematology
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Plasma Fractionation manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Plasma Fractionation in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Plasma Fractionation.
The global Plasma Fractionation market size is expected to reach US$ 47210 million by 2029, growing at a CAGR of 7.6% from 2023 to 2029. The market is mainly driven by the significant applications of Plasma Fractionation in various end use industries. The expanding demands from the Immunology, Hematology and Others,, are propelling Plasma Fractionation market. Albumin, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Immune Globulin segment is estimated at % CAGR for the next seven-year period.
Global Plasma Fractionation key players include Takeda, CSL, Grifols, Octapharma, Kedrion, etc. Global top five manufacturers hold a share about 75%.
North America is the largest market, with a share over 40%, followed by Europe and China, both have a share about 40 percent.
In terms of product, Immune Globulin is the largest segment, with a share about 50%. And in terms of application, the largest application is Immunology, followed by Hematology.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Plasma Fractionation, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Plasma Fractionation market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Plasma Fractionation market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Plasma Fractionation sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Plasma Fractionation covered in this report include Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL and RAAS, etc.
The global Plasma Fractionation market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Global Plasma Fractionation market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Plasma Fractionation market, Segment by Type:
Albumin
Immune Globulin
Coagulation Factor
Others
Global Plasma Fractionation market, by Application
Immunology
Hematology
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Plasma Fractionation manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Plasma Fractionation in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Plasma Fractionation Market Overview
1.1 Plasma Fractionation Product Overview
1.2 Plasma Fractionation Market Segment by Type
1.2.1 Albumin
1.2.2 Immune Globulin
1.2.3 Coagulation Factor
1.2.4 Others
1.3 Global Plasma Fractionation Market Size by Type
1.3.1 Global Plasma Fractionation Market Size Overview by Type (2018-2029)
1.3.2 Global Plasma Fractionation Historic Market Size Review by Type (2018-2023)
1.3.3 Global Plasma Fractionation Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Plasma Fractionation Sales Breakdown by Type (2018-2023)
1.4.2 Europe Plasma Fractionation Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Plasma Fractionation Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Plasma Fractionation Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Plasma Fractionation Sales Breakdown by Type (2018-2023)
2 Global Plasma Fractionation Market Competition by Company
2.1 Global Top Players by Plasma Fractionation Sales (2018-2023)
2.2 Global Top Players by Plasma Fractionation Revenue (2018-2023)
2.3 Global Top Players by Plasma Fractionation Price (2018-2023)
2.4 Global Top Manufacturers Plasma Fractionation Manufacturing Base Distribution, Sales Area, Product Type
2.5 Plasma Fractionation Market Competitive Situation and Trends
2.5.1 Plasma Fractionation Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Plasma Fractionation Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Plasma Fractionation as of 2022)
2.7 Date of Key Manufacturers Enter into Plasma Fractionation Market
2.8 Key Manufacturers Plasma Fractionation Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Plasma Fractionation Status and Outlook by Region
3.1 Global Plasma Fractionation Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Plasma Fractionation Historic Market Size by Region
3.2.1 Global Plasma Fractionation Sales in Volume by Region (2018-2023)
3.2.2 Global Plasma Fractionation Sales in Value by Region (2018-2023)
3.2.3 Global Plasma Fractionation Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Plasma Fractionation Forecasted Market Size by Region
3.3.1 Global Plasma Fractionation Sales in Volume by Region (2024-2029)
3.3.2 Global Plasma Fractionation Sales in Value by Region (2024-2029)
3.3.3 Global Plasma Fractionation Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Plasma Fractionation by Application
4.1 Plasma Fractionation Market Segment by Application
4.1.1 Immunology
4.1.2 Hematology
4.1.3 Others
4.2 Global Plasma Fractionation Market Size by Application
4.2.1 Global Plasma Fractionation Market Size Overview by Application (2018-2029)
4.2.2 Global Plasma Fractionation Historic Market Size Review by Application (2018-2023)
4.2.3 Global Plasma Fractionation Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Plasma Fractionation Sales Breakdown by Application (2018-2023)
4.3.2 Europe Plasma Fractionation Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Plasma Fractionation Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Plasma Fractionation Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Plasma Fractionation Sales Breakdown by Application (2018-2023)
5 North America Plasma Fractionation by Country
5.1 North America Plasma Fractionation Historic Market Size by Country
5.1.1 North America Plasma Fractionation Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Plasma Fractionation Sales in Volume by Country (2018-2023)
5.1.3 North America Plasma Fractionation Sales in Value by Country (2018-2023)
5.2 North America Plasma Fractionation Forecasted Market Size by Country
5.2.1 North America Plasma Fractionation Sales in Volume by Country (2024-2029)
5.2.2 North America Plasma Fractionation Sales in Value by Country (2024-2029)
6 Europe Plasma Fractionation by Country
6.1 Europe Plasma Fractionation Historic Market Size by Country
6.1.1 Europe Plasma Fractionation Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Plasma Fractionation Sales in Volume by Country (2018-2023)
6.1.3 Europe Plasma Fractionation Sales in Value by Country (2018-2023)
6.2 Europe Plasma Fractionation Forecasted Market Size by Country
6.2.1 Europe Plasma Fractionation Sales in Volume by Country (2024-2029)
6.2.2 Europe Plasma Fractionation Sales in Value by Country (2024-2029)
7 Asia-Pacific Plasma Fractionation by Region
7.1 Asia-Pacific Plasma Fractionation Historic Market Size by Region
7.1.1 Asia-Pacific Plasma Fractionation Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Plasma Fractionation Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Plasma Fractionation Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Plasma Fractionation Forecasted Market Size by Region
7.2.1 Asia-Pacific Plasma Fractionation Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Plasma Fractionation Sales in Value by Region (2024-2029)
8 Latin America Plasma Fractionation by Country
8.1 Latin America Plasma Fractionation Historic Market Size by Country
8.1.1 Latin America Plasma Fractionation Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Plasma Fractionation Sales in Volume by Country (2018-2023)
8.1.3 Latin America Plasma Fractionation Sales in Value by Country (2018-2023)
8.2 Latin America Plasma Fractionation Forecasted Market Size by Country
8.2.1 Latin America Plasma Fractionation Sales in Volume by Country (2024-2029)
8.2.2 Latin America Plasma Fractionation Sales in Value by Country (2024-2029)
9 Middle East and Africa Plasma Fractionation by Country
9.1 Middle East and Africa Plasma Fractionation Historic Market Size by Country
9.1.1 Middle East and Africa Plasma Fractionation Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Plasma Fractionation Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Plasma Fractionation Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Plasma Fractionation Forecasted Market Size by Country
9.2.1 Middle East and Africa Plasma Fractionation Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Plasma Fractionation Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Takeda
10.1.1 Takeda Company Information
10.1.2 Takeda Introduction and Business Overview
10.1.3 Takeda Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Takeda Plasma Fractionation Products Offered
10.1.5 Takeda Recent Development
10.2 CSL
10.2.1 CSL Company Information
10.2.2 CSL Introduction and Business Overview
10.2.3 CSL Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
10.2.4 CSL Plasma Fractionation Products Offered
10.2.5 CSL Recent Development
10.3 Grifols
10.3.1 Grifols Company Information
10.3.2 Grifols Introduction and Business Overview
10.3.3 Grifols Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Grifols Plasma Fractionation Products Offered
10.3.5 Grifols Recent Development
10.4 Octapharma
10.4.1 Octapharma Company Information
10.4.2 Octapharma Introduction and Business Overview
10.4.3 Octapharma Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Octapharma Plasma Fractionation Products Offered
10.4.5 Octapharma Recent Development
10.5 Kedrion
10.5.1 Kedrion Company Information
10.5.2 Kedrion Introduction and Business Overview
10.5.3 Kedrion Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Kedrion Plasma Fractionation Products Offered
10.5.5 Kedrion Recent Development
10.6 LFB Group
10.6.1 LFB Group Company Information
10.6.2 LFB Group Introduction and Business Overview
10.6.3 LFB Group Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
10.6.4 LFB Group Plasma Fractionation Products Offered
10.6.5 LFB Group Recent Development
10.7 Biotest
10.7.1 Biotest Company Information
10.7.2 Biotest Introduction and Business Overview
10.7.3 Biotest Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Biotest Plasma Fractionation Products Offered
10.7.5 Biotest Recent Development
10.8 BPL
10.8.1 BPL Company Information
10.8.2 BPL Introduction and Business Overview
10.8.3 BPL Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
10.8.4 BPL Plasma Fractionation Products Offered
10.8.5 BPL Recent Development
10.9 RAAS
10.9.1 RAAS Company Information
10.9.2 RAAS Introduction and Business Overview
10.9.3 RAAS Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
10.9.4 RAAS Plasma Fractionation Products Offered
10.9.5 RAAS Recent Development
10.10 CBPO
10.10.1 CBPO Company Information
10.10.2 CBPO Introduction and Business Overview
10.10.3 CBPO Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
10.10.4 CBPO Plasma Fractionation Products Offered
10.10.5 CBPO Recent Development
10.11 Hualan Bio
10.11.1 Hualan Bio Company Information
10.11.2 Hualan Bio Introduction and Business Overview
10.11.3 Hualan Bio Plasma Fractionation Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Hualan Bio Plasma Fractionation Products Offered
10.11.5 Hualan Bio Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Plasma Fractionation Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Plasma Fractionation Industrial Chain Analysis
11.4 Plasma Fractionation Market Dynamics
11.4.1 Plasma Fractionation Industry Trends
11.4.2 Plasma Fractionation Market Drivers
11.4.3 Plasma Fractionation Market Challenges
11.4.4 Plasma Fractionation Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Plasma Fractionation Distributors
12.3 Plasma Fractionation Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
